TMO
Thermo Fisher Scientific
·
$532.48
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤
Terminal终端 ↗
Thermo Fisher Scientific · Health Care
TMO
$532.48
Thermo Fisher Scientific Inc. is an American life science and clinical research company.ThermoFisherScientificInc.是一家美国生命科学和临床研究公司。
Mixed profile混合特征
Large cap大盘
$198B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高;等待回撤
You missed the bottoming entry — the low already formed and price is now extended (momentum is fading — the daily moment已错过筑底入场——低点已经形成,目前价格已拉伸(动量正在衰竭——日线动量已开始掉头向下)。不要追高;等待回调至 10 日均线或下一个周期低点。若已持有则继续持有。
Price Chart价格图表
Key Statistics关键统计
Price价格
$532.48
16.6% below 52-week high低于52周高点 16.6%
Market Cap市值
$198B
Normal volume正常成交量
P/E Ratio市盈率
29.4x
28.9x sector median
Forward P/E预测市盈率
19.5x
EPS每股收益 $18.09
Beta贝塔
0.81
Moves about 0.8x the market波动幅度约为市场的 0.8 倍
Dividend Yield股息收益率
0.35%
RSI (14)RSI(14)
63
Elevated偏高
Next Earnings下次财报
2026-07-22 (3d)
Volatility Rank波动率分位
44th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
1.4% of float
Performance价格表现
| Period周期 | TMO | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +1.0% | -1.5% | Beat the index by 2.5 points跑赢指数 2.5 个百分点 |
| 1 Month近1月 | +15.3% | +0.6% | Beat the index by 14.7 points跑赢指数 14.7 个百分点 |
| 3 Months近3月 | +1.1% | +4.7% | Lagged the index by 3.6 points落后指数 3.6 个百分点 |
| 6 Months近6月 | -13.9% | +7.8% | Lagged the index by 21.7 points落后指数 21.7 个百分点 |
| Year to date年初至今 | -10.0% | +9.1% | Lagged the index by 19.1 points落后指数 19.1 个百分点 |
| 1 Year近1年 | +25.6% | +19.4% | Beat the index by 6.2 points跑赢指数 6.2 个百分点 |
| 3 Years近3年 | +2.6% | +69.4% | Lagged the index by 66.8 points落后指数 66.8 个百分点 |
| 5 Years近5年 | +3.8% | +83.9% | Lagged the index by 80.1 points落后指数 80.1 个百分点 |
Technicals技术面
Active signals活跃信号
1-Day Return (cross-sectional rank → top/bottom gainers)Valuation cheapness percentile (0–1, higher = cheaper vs peers)Insider Power (0–100) — quality-weighted Form-4 open-market trades (role × size × recency); 50 = neutralInsider Sell signal — fires when Insider Power ≤ 40 (net selling on quality-weighted basis)Ichimoku — Price Above Cloud
RSI (14)RSI(14)
63
Elevated偏高
vs 50-day相对50日均线
+10.0% vs 50-day avg
vs 200-day相对200日均线
+0.7% vs 200-day avg
Trend strength (ADX)趋势强度(ADX)
35
Strong trend趋势强劲
Volatility rank波动率分位
44th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$519.10
Don't chase above不追高于
$532.50
Stop止损
$461.70
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
3
days until next report天后公布财报
2026-07-22
Estimates being cut预期下调
Post-earnings drift: -8.1% (20d)财报后漂移:-8.1%(20日)
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | TMO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 29.43x | 28.92 | 48% |
| P/E (forward)市盈率(预测) | 19.5x | — | — |
| P/B市净率 | 3.70x | 3.52 | 46% |
| P/S市销率 | 4.44x | 3.02 | 33% |
| Earnings yield盈利收益率 | 3.40% | 2.72 | 62% |
| FCF yield自由现金流收益率 | 3.18% | 3.94 | 38% |
| Shareholder yield股东收益率 | 1.84% | 1.89 | 48% |
| EV/EBITDA企业价值/EBITDA | 26.22x | 18.21 | 28% |
| P/FCF市值/自由现金流 | 31.43x | 22.42 | 28% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 6.7%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 2.1%
Free Cash Flow自由现金流
Margins利润率
12.6%Return on Equity股本回报率
6.1%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 3.73 |
| Current ratio流动比率 | 1.89 |
Capital Allocation资本配置
| Buybacks (TTM)回购(TTM) | $3.0B |
| Stock-based comp股权薪酬 | $310.0M |
| Share count change (1y)股数变化(1年) | -1.5% |
Piotroski皮奥特罗斯基 4/7
Altman Z阿尔特曼Z: safe (3.6)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 39% of its sector on blended multiples综合估值倍数低于行业内 39% 的公司
Beta市场敏感度
0.81×
0.21×3×
Moves about 0.8× the market波动幅度约为市场的 0.8 倍
Financial Health财务健康
4/7
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
0.35%
Pays a dividend (0.35% yield)有分红(收益率 0.35%)
Why Is It Moving为何波动
News新闻
2 recent stories — mixed2 篇最新报道,多空参半
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健(等权)」主题 — 46 个主题中第 6 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +21.1%空头仓位变动 +21.1%
Technical技术面
TMO RSI reached overboughtTMO RSI进入超买
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.34%
Expected weekly move预期周波动
±5.22%
Call wall看涨密集区
$540
Put wall看跌密集区
$515
Gamma flip伽玛翻转
$505
25d risk reversal25d风险逆转
-0.8%
Skew: 偏斜:balanced
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$96.4M net (0 buyers, 6 sellers)-$96.4M 净值(0 买家,6 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| D1 Capital Partners | A | New position新建仓 | 3.2% | 2026-03-31 |
| Viking Global (Halvorsen) | B | Adding加仓 | 2.3% | 2026-03-31 |
| Third Point (Loeb) | B | exitexit | 0.0% | 2026-03-31 |
| Polen Capital Management | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TOP WATCH
NEARING A HIGH
Jul 16, 2026
TMO RSI reached overboughtTMO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $543.19.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$543.19。
Jul 13, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jul 10, 2026
TMO reclaimed its 200-day averageTMO 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $527.05.收盘重回200日均线 — 经典的多头分界线。$527.05。
Jul 8, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 1, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jun 30, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jun 26, 2026
UPTREND → BUY ZONE上涨趋势 → 买入区
BUY买入
Jun 26, 2026
TMO weekly MACD crossed upTMO 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Showing last 15 of显示最近15条,共 3842 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.29
Value价值
-0.5
Quality质量
-0.6
Investment资本投入
-0.3
Shareholder payout股东回报
-0.6
Low volatility低波动
+0.5
Low market beta低市场敏感度
+0.0
Earnings quality盈利质量
-0.6
Short interest空头兴趣
+1.0
Company Profile公司档案
Thermo Fisher Scientific Inc. is an American life science and clinical research company.ThermoFisherScientificInc.是一家美国生命科学和临床研究公司。
Demand chain:需求链: Contracted bookings (RPO) accelerating (+13% YoY to ~$28B, 0.6× revenue) — signed demand locked in ahead of recognition已签约订单(RPO)加速(同比+13%,约 $28B,覆盖营收 0.6 倍)——已锁定、尚未确认的需求
Recent News最新动态
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider
GlobeNewswire Inc.
2026-07-17
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate
GlobeNewswire Inc.
2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。